Attuwaybi Bashir, Kozar Rosemary A, Gates Keith S, Moore-Olufemi Stacey, Sato Norio, Weisbrodt Norman W, Moore Frederick A
Department of Surgery, University of Texas-Houston, Houston, Texas 77030, USA.
J Trauma. 2004 Apr;56(4):749-58; discussion 758-9. doi: 10.1097/01.ta.0000119686.33487.65.
Hypertonic saline (HTS) has been shown to modulate the inflammatory response after shock. We have previously demonstrated that heme oygenase-1 (HO-1) induction is protective against gut dysfunction in models of shock-induced gut ischemia/reperfusion (I/R). We therefore hypothesized that HTS prevents gut inflammation, injury, and impaired transit by inducing HO-1 in a model of gut I/R.
Rats underwent 60 minutes of superior mesenteric artery occlusion (SMAO) and then were resuscitated with 4 mL/kg of HTS, an equal volume of lactated Ringer's (LR) solution (4 mL/kg, low volume), or equal salt LR solution (32 mL/kg, high volume) and compared with SMAO alone or shams. A separate group was pretreated with the HO-1 blocker Sn protoporphyrin IX (SNP IX) before SMAO plus HTS. At 6 hours of reperfusion, transit was determined and ileum harvested for HO-1 (anti-inflammatory) and inducible nitric oxide synthase (proinflammatory) immunoreactivity, myeloperoxidase (MPO) activity, and histologic injury. Data are expressed as mean +/- SEM (analysis of variance).
Intestinal transit was severely impaired after SMAO (2.5 +/- 0.1), improved with low- and high-volume LR solution (3.2 +/- 0.2 and 3.1 +/- 0.1, not significant), but returned to sham (4.6 +/- 0.2) with HTS (4.8 +/- 0.2). Pretreatment with SNP abrogated this protective effect. Myeloperoxidase activity was significantly increased by SMAO (SMAO, 2.3 +/- 0.3; sham, 0.4 +/- 0.05), lessened by low- and high-volume LR solution (1.5 +/- 0.3 and 1.7 +/- 0.4), but returned to sham levels with HTS (1.0 +/- 0.01). Activity with SNP IX pretreatment was significantly increased (4.04 +/- 0.8). Mucosal injury followed a similar pattern. Inducible nitric oxide synthase was increased by SMAO and low- and high-volume LR solution (0.8 +/- 0.2, 0.8 +/- 0.03, and 0.8 +/- 0.02, respectively; sham, 0.5 +/- 0.02), but significantly reduced by HTS (0.7 +/- 0.02). HO-1 was induced by SMAO and low- and high-volume LR solution (0.33 +/- 0.02, 0.32 +/- 0.03, and 0.37 +/- 0.4, respectively; sham, 0.0 +/- 0.0), but was further increased with HTS (0.49 +/- 0.04).
HTS resuscitation protects against inflammation, injury, and impaired intestinal transit after gut I/R in part by inducing HO-1. This is a novel mechanism of HO-1 protection.
高渗盐水(HTS)已被证明可调节休克后的炎症反应。我们之前已经证明,在休克诱导的肠道缺血/再灌注(I/R)模型中,血红素加氧酶-1(HO-1)的诱导对肠道功能障碍具有保护作用。因此,我们推测HTS通过在肠道I/R模型中诱导HO-1来预防肠道炎症、损伤和转运受损。
大鼠接受60分钟的肠系膜上动脉闭塞(SMAO),然后分别用4 mL/kg的HTS、等体积的乳酸林格氏液(LR)(4 mL/kg,低容量)或等盐LR溶液(32 mL/kg,高容量)进行复苏,并与单纯SMAO组或假手术组进行比较。另一组在SMAO加HTS之前用HO-1阻滞剂锡原卟啉IX(SNP IX)进行预处理。在再灌注6小时时,测定转运情况,并采集回肠用于检测HO-1(抗炎)和诱导型一氧化氮合酶(促炎)免疫反应性、髓过氧化物酶(MPO)活性和组织学损伤。数据以平均值±标准误表示(方差分析)。
SMAO后肠道转运严重受损(2.5±0.1),低容量和高容量LR溶液可使其改善(3.2±0.2和3.1±0.1,无显著性差异),但HTS可使其恢复至假手术水平(4.8±0.2)。SNP预处理消除了这种保护作用。SMAO可使MPO活性显著增加(SMAO组为2.3±0.3;假手术组为0.4±0.05),低容量和高容量LR溶液可使其降低(1.5±0.3和1.7±0.4),但HTS可使其恢复至假手术水平(1.0±0.01)。SNP IX预处理后的活性显著增加(4.04±0.8)。黏膜损伤呈现类似模式。SMAO以及低容量和高容量LR溶液可使诱导型一氧化氮合酶增加(分别为0.8±0.2、0.8±0.03和0.8±0.02;假手术组为0.5±0.02),但HTS可使其显著降低(0.7±0.02)。SMAO以及低容量和高容量LR溶液可诱导HO-1(分别为0.33±0.02、0.32±0.03和0.37±0.4;假手术组为0.0±0.0),但HTS可使其进一步增加(0.49±0.04)。
HTS复苏可部分通过诱导HO-1来预防肠道I/R后的炎症、损伤和肠道转运受损。这是HO-1保护的一种新机制。